Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial

Agüera-Morales, E; Fernández-Sánchez, VE; Navarro-Mascarell, G; Cabezas-Rodríguez, JA; Peña-Toledo, MA; Reyes-Rodríguez, V; Postigo-Pozo, MJ; Patrignani-Ochoa, G; Geniz-Clavijo, MA; Márquez-Infante, C; Tallon-Aguilar, L; Tinoco-González, J; Padillo-Ruiz, J; Valladares-Sánchez, A; Caballero-Eraso, C; López-Ramírez, C; Alcázar-Caballero, RM; Leyva-Fernández, L; Rodríguez-Acosta, A; Maldonado-Sánchez, R; García-Martín, ML; Somoza-Ramírez, ML; Quijano-Ruiz, B; Macías-Sánchez, MD; Carmona-Sánchez, G; Fernández-López, O; Fernández-Fernández, O – 2025 – 10.3389/fneur.2025.1655124